Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 10 - 20 entities : Innate pharma sa save search
AlzeCure Presents New Data with its Preventive Treatment Alzstatin at the Alzheimer Conference CTAD AlzeCure Pharma announced that an abstract with new preclinical Alzstatin data has been accepted for ...
Published: 2022-10-20 (Crawled : 09:00) - biospace.com/
DNLI | $16.455 -0.87% 120K
|
Health Technology
|
| O: -5.24%
H: 10.87%
C: 5.45%
treatment pharma conference preclinical alzheimer
Innate Pharma 2023 Financial Calendar
Published: 2022-10-20 (Crawled : 07:00) - biospace.com/
NVO | $123.43 0.55% 1.4M
|
Health Technology
|
| O: -0.35%
H: 1.28%
C: -0.17%
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: -1.19%
H: 0.0%
C: 0.0%
IPHA | $2.35 2.3K
|
Health Technology
|
| O: 0.0%
H: 2.4%
C: 1.92%
pharma financial
Innate Pharma 2023 Financial Calendar Innate Pharma SA released its 2023 financial calendar. argenx to Report Third Quarter 2022 Financial Results and Business Update on October 27, 2022 argenx announc...
Published: 2022-10-20 (Crawled : 07:00) - biospace.com/
NVO | $123.43 0.55% 1.4M
|
Health Technology
|
| O: -0.35%
H: 1.28%
C: -0.17%
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: -1.19%
H: 0.0%
C: 0.0%
IPHA | $2.35 2.3K
|
Health Technology
|
| O: 0.0%
H: 2.4%
C: 1.92%
DNLI | $16.455 -0.87% 120K
|
Health Technology
|
| O: -5.24%
H: 10.87%
C: 5.45%
pharma report financial update results
Gainers vs Losers
| 79% | 21% |
Top 10 Gainers
AGBA | News | $1.22 205.0% 86M
|
Finance
EGOX | $0.0606 68.33% 250M
|
NVFY | $3.45 63.51% 20M
|
Consumer Durables
ZCMD | $1.98 36.55% 27M
|
Commercial Services
CHRO | $1.66 35.51% 70K
|
n/a
INDO | $5.43 33.09% 10M
|
Energy Minerals
PAPL | $2.07 26.22% 550K
|
RWOD | $10.08 26.05% 5.6M
|
n/a
AULT | $0.304 25.57% 47M
|
Manufacturing
HUSA 4 | $2.07 23.95% 2.1M
|
Energy Minerals
Your saved searches
Save your searches and get alerts when important news are released.